Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development
about
Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status.Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro.Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.Development of a copper-clioquinol formulation suitable for intravenous use.Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
P2860
Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Nanoscale Reaction Vessels Des ...... le for Preclinical Development
@ast
Nanoscale Reaction Vessels Des ...... le for Preclinical Development
@en
Nanoscale Reaction Vessels Des ...... le for Preclinical Development
@nl
type
label
Nanoscale Reaction Vessels Des ...... le for Preclinical Development
@ast
Nanoscale Reaction Vessels Des ...... le for Preclinical Development
@en
Nanoscale Reaction Vessels Des ...... le for Preclinical Development
@nl
prefLabel
Nanoscale Reaction Vessels Des ...... le for Preclinical Development
@ast
Nanoscale Reaction Vessels Des ...... le for Preclinical Development
@en
Nanoscale Reaction Vessels Des ...... le for Preclinical Development
@nl
P2093
P2860
P3181
P1433
P1476
Nanoscale Reaction Vessels Des ...... le for Preclinical Development
@en
P2093
Armaan Malhotra
Ian Backstrom
Malathi Anantha
Marcel B Bally
Mohamed Wehbe
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0153416
P407
P577
2016-04-07T00:00:00Z